JP2019520377A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520377A5 JP2019520377A5 JP2018569065A JP2018569065A JP2019520377A5 JP 2019520377 A5 JP2019520377 A5 JP 2019520377A5 JP 2018569065 A JP2018569065 A JP 2018569065A JP 2018569065 A JP2018569065 A JP 2018569065A JP 2019520377 A5 JP2019520377 A5 JP 2019520377A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- aqueous solution
- component
- component composition
- acetylsalicylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007864 aqueous solution Substances 0.000 claims 23
- 239000000203 mixture Substances 0.000 claims 17
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 16
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 16
- 239000002775 capsule Substances 0.000 claims 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- 150000007524 organic acids Chemical class 0.000 claims 5
- 239000000654 additive Substances 0.000 claims 4
- 208000010125 myocardial infarction Diseases 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000000243 solution Substances 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- ZSTXTALVALLOGG-UHFFFAOYSA-N 2-hexadecoxybenzoic acid Chemical compound CCCCCCCCCCCCCCCCOC1=CC=CC=C1C(O)=O ZSTXTALVALLOGG-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- 150000005323 carbonate salts Chemical class 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 239000001508 potassium citrate Substances 0.000 claims 2
- 229960002635 potassium citrate Drugs 0.000 claims 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims 2
- 235000011082 potassium citrates Nutrition 0.000 claims 2
- 239000001509 sodium citrate Substances 0.000 claims 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 claims 1
- 150000000996 L-ascorbic acids Chemical class 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 1
- 235000011054 acetic acid Nutrition 0.000 claims 1
- 150000001242 acetic acid derivatives Chemical class 0.000 claims 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 1
- 235000015165 citric acid Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- -1 organic acid salt Chemical class 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022182537A JP7520941B2 (ja) | 2016-06-28 | 2022-11-15 | 二成分組成物およびカプセル |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20161073 | 2016-06-28 | ||
| NO20161073 | 2016-06-28 | ||
| PCT/EP2017/065970 WO2018002124A1 (en) | 2016-06-28 | 2017-06-28 | Two-component composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022182537A Division JP7520941B2 (ja) | 2016-06-28 | 2022-11-15 | 二成分組成物およびカプセル |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019520377A JP2019520377A (ja) | 2019-07-18 |
| JP2019520377A5 true JP2019520377A5 (enExample) | 2020-07-27 |
Family
ID=59285173
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018569065A Pending JP2019520377A (ja) | 2016-06-28 | 2017-06-28 | 二成分組成物 |
| JP2022182537A Active JP7520941B2 (ja) | 2016-06-28 | 2022-11-15 | 二成分組成物およびカプセル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022182537A Active JP7520941B2 (ja) | 2016-06-28 | 2022-11-15 | 二成分組成物およびカプセル |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US11918554B2 (enExample) |
| EP (2) | EP3871677A1 (enExample) |
| JP (2) | JP2019520377A (enExample) |
| KR (1) | KR102397334B1 (enExample) |
| CN (2) | CN109789152A (enExample) |
| AU (1) | AU2017288465B2 (enExample) |
| BR (1) | BR112018076553A2 (enExample) |
| CA (1) | CA3027462A1 (enExample) |
| CY (1) | CY1124724T1 (enExample) |
| DK (1) | DK3474858T3 (enExample) |
| EA (1) | EA201990093A1 (enExample) |
| ES (1) | ES2897981T3 (enExample) |
| HR (1) | HRP20211761T1 (enExample) |
| HU (1) | HUE056659T2 (enExample) |
| IL (1) | IL263982B (enExample) |
| LT (1) | LT3474858T (enExample) |
| MX (1) | MX388400B (enExample) |
| MY (1) | MY195384A (enExample) |
| NZ (1) | NZ749230A (enExample) |
| PL (1) | PL3474858T3 (enExample) |
| PT (1) | PT3474858T (enExample) |
| RS (1) | RS62574B1 (enExample) |
| SI (1) | SI3474858T1 (enExample) |
| SM (1) | SMT202100645T1 (enExample) |
| WO (1) | WO2018002124A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3474858T (lt) | 2016-06-28 | 2021-12-27 | Asamedic As | Dviejų komponentų kompozicija, apimanti acetilsalicilo rūgštį |
| EP3501522A1 (en) | 2017-12-22 | 2019-06-26 | Asamedic AS | Compositions comprising acetylsalicylic acid and a phosphate salt |
| EP3501523A1 (en) | 2017-12-22 | 2019-06-26 | Asamedic AS | Two-component compositions comprising acetyl salicylic acid and a carbonate salt |
| WO2020150460A1 (en) * | 2019-01-18 | 2020-07-23 | Milne Iii Donald A | Micronized aspirin formulation |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB912894A (en) * | 1959-11-02 | 1962-12-12 | Guy Leopold Van Moorleghem | Method for the preparing a solution of aspirin for injection and product obtained thereby |
| AT222276B (de) * | 1959-11-02 | 1962-07-10 | Guy Leopold Van Moorleghem | Verfahren zur Herstellung einer injizierbaren Lösung von Acetylsalicylsäure |
| FR304M (fr) * | 1960-08-19 | 1961-03-20 | Guy | Soluté injectable d'aspirine et son procédé de fabrication. |
| FR2320759A1 (fr) | 1975-08-11 | 1977-03-11 | Union Pharma Scient Appl | Solution d'acide acetylsalicylique extemporanee injectable |
| AU632602B2 (en) | 1989-08-02 | 1993-01-07 | John David Arnold | Method and preparation for reducing risk of myocardial infarction |
| US5157030A (en) | 1989-08-25 | 1992-10-20 | Alexander Galat | Rapidly soluble aspirin compositions and method |
| FR2712809B1 (fr) | 1993-11-26 | 1996-04-12 | Union Pharma Scient Appl | Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide. |
| JPH07157432A (ja) * | 1993-12-07 | 1995-06-20 | Daikyo Yakuhin Kogyo Kk | 貼付剤 |
| GB9701160D0 (en) * | 1997-01-21 | 1997-03-12 | Parkinson Sidney | Medicament dispenser |
| IT1292677B1 (it) | 1997-02-28 | 1999-02-11 | Bormioli Metalplast Spa | Confezione per mantenere separati dei prodotti prima dell'uso. |
| US5776431A (en) | 1997-03-26 | 1998-07-07 | Galat; Alexander | Water-soluble aspirin composition |
| JP4126405B2 (ja) * | 1998-02-02 | 2008-07-30 | 甲陽ケミカル株式会社 | 芳香族カルボン酸類の溶解度向上化水溶液 |
| NO309761B1 (no) * | 1999-05-03 | 2001-03-26 | Anders Aelveborn | Beholder eller kapsel for adskilt oppbevaring av to- komponents blandbare materialer |
| GB0018322D0 (en) * | 2000-07-27 | 2000-09-13 | Boots Co Plc | Pharmaceutical compositions |
| US7029701B2 (en) | 2000-09-11 | 2006-04-18 | Andrx Pharmaceuticals, Llc | Composition for the treatment and prevention of ischemic events |
| US7670612B2 (en) | 2002-04-10 | 2010-03-02 | Innercap Technologies, Inc. | Multi-phase, multi-compartment capsular delivery apparatus and methods for using same |
| EP1525765A1 (en) | 2002-06-25 | 2005-04-27 | Nokia Corporation | Routing method and network element |
| ITMI20022619A1 (it) | 2002-12-11 | 2004-06-12 | Ind Italiana Integratori Trei S P A | Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata. |
| CN1418635A (zh) * | 2002-12-19 | 2003-05-21 | 王登之 | 治疗感冒发热的阿司匹林口腔崩解片及其制备方法 |
| EP1621200A1 (en) * | 2004-07-26 | 2006-02-01 | Fournier Laboratories Ireland Limited | Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate |
| US7598233B2 (en) * | 2005-03-28 | 2009-10-06 | Kowa Co., Ltd. | Method for treating thrombosis |
| US20060292225A1 (en) | 2005-06-24 | 2006-12-28 | Felix Arthur M | Water soluble analgesic formulations and methods for production |
| US20070092561A1 (en) | 2005-06-24 | 2007-04-26 | Don Milne | Water-Soluble Aspirin Composition |
| US7614496B2 (en) | 2005-08-29 | 2009-11-10 | Steven Dvorak | Aqueous solution of an analgesic and a dispenser therefor |
| WO2009007768A1 (en) | 2007-07-06 | 2009-01-15 | Gumlink A/S | Compressed tablet comprising polyol |
| CN101632647A (zh) * | 2008-07-21 | 2010-01-27 | 北京迈劲医药科技有限公司 | 阿司匹林与碱性药物组成的复方制剂的制备方法 |
| US20100125242A1 (en) * | 2008-11-15 | 2010-05-20 | Pharmstar Pharmaceuticals, Inc. | Emergency dose medication administration device |
| WO2010065936A1 (en) * | 2008-12-04 | 2010-06-10 | Chongxi Yu | High penetration compositions and their applications |
| US8173625B2 (en) * | 2009-05-08 | 2012-05-08 | Theaprin Pharmaceuticals Inc. | Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine |
| US8580853B2 (en) | 2011-06-13 | 2013-11-12 | Howard PHYKITT | Analgesic composition and method of making the same |
| HUE039878T2 (hu) * | 2012-09-25 | 2019-02-28 | Bayer Pharma AG | Regorafenib és acetilszalicilsav kombinációja kolorektális rák kezelésére |
| PT3060203T (pt) | 2013-10-23 | 2017-10-27 | Bayer Healthcare Llc | Comprimido efervescente que contém um teor elevado de aspirina |
| EP2777802B1 (en) | 2013-12-03 | 2016-03-16 | Capsugel Belgium NV | Multi-compartment dosage form articles |
| WO2017001468A1 (en) * | 2015-07-02 | 2017-01-05 | Asamedic As | Two-component composition |
| LT3474858T (lt) | 2016-06-28 | 2021-12-27 | Asamedic As | Dviejų komponentų kompozicija, apimanti acetilsalicilo rūgštį |
| EP3501523A1 (en) | 2017-12-22 | 2019-06-26 | Asamedic AS | Two-component compositions comprising acetyl salicylic acid and a carbonate salt |
| EP3501522A1 (en) | 2017-12-22 | 2019-06-26 | Asamedic AS | Compositions comprising acetylsalicylic acid and a phosphate salt |
-
2017
- 2017-06-28 LT LTEPPCT/EP2017/065970T patent/LT3474858T/lt unknown
- 2017-06-28 AU AU2017288465A patent/AU2017288465B2/en active Active
- 2017-06-28 CA CA3027462A patent/CA3027462A1/en active Pending
- 2017-06-28 HR HRP20211761TT patent/HRP20211761T1/hr unknown
- 2017-06-28 US US16/311,251 patent/US11918554B2/en active Active
- 2017-06-28 SI SI201730985T patent/SI3474858T1/sl unknown
- 2017-06-28 MY MYPI2018002835A patent/MY195384A/en unknown
- 2017-06-28 CN CN201780039928.2A patent/CN109789152A/zh active Pending
- 2017-06-28 KR KR1020197001083A patent/KR102397334B1/ko active Active
- 2017-06-28 ES ES17735455T patent/ES2897981T3/es active Active
- 2017-06-28 NZ NZ749230A patent/NZ749230A/en unknown
- 2017-06-28 CN CN202410125479.5A patent/CN117982446A/zh active Pending
- 2017-06-28 PT PT177354552T patent/PT3474858T/pt unknown
- 2017-06-28 RS RS20211418A patent/RS62574B1/sr unknown
- 2017-06-28 HU HUE17735455A patent/HUE056659T2/hu unknown
- 2017-06-28 BR BR112018076553-8A patent/BR112018076553A2/pt not_active Application Discontinuation
- 2017-06-28 DK DK17735455.2T patent/DK3474858T3/da active
- 2017-06-28 MX MX2018015965A patent/MX388400B/es unknown
- 2017-06-28 SM SM20210645T patent/SMT202100645T1/it unknown
- 2017-06-28 EP EP21169653.9A patent/EP3871677A1/en active Pending
- 2017-06-28 EP EP17735455.2A patent/EP3474858B1/en active Active
- 2017-06-28 WO PCT/EP2017/065970 patent/WO2018002124A1/en not_active Ceased
- 2017-06-28 JP JP2018569065A patent/JP2019520377A/ja active Pending
- 2017-06-28 EA EA201990093A patent/EA201990093A1/ru unknown
- 2017-06-28 PL PL17735455T patent/PL3474858T3/pl unknown
-
2018
- 2018-12-26 IL IL263982A patent/IL263982B/en unknown
-
2021
- 2021-03-29 US US17/215,791 patent/US11369581B2/en active Active
- 2021-11-11 CY CY20211100985T patent/CY1124724T1/el unknown
-
2022
- 2022-11-15 JP JP2022182537A patent/JP7520941B2/ja active Active
-
2024
- 2024-01-11 US US18/410,324 patent/US20240216318A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019520377A5 (enExample) | ||
| PE20130063A1 (es) | Formulaciones orales y sales lipofilicas de metilnaltrexona | |
| JP2014218522A5 (enExample) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| NO20082744L (no) | Oral farmasoytisk doseform omfattende som aktive ingredienser en proton pumpeinhibitor sammen med acetylsalicylsyre | |
| RU2017134002A (ru) | Стабильные композиции тетрагидробиоптерина | |
| JP2015527385A5 (enExample) | ||
| RU2017143849A (ru) | Твёрдый состав для перорального применения, содержащий иринотекан, и способ его получения | |
| EA201891267A1 (ru) | Фармацевтическая композиция, содержащая действенный ингибитор urat1 | |
| JP2016503058A5 (enExample) | ||
| JP2015522080A5 (enExample) | ||
| JP2019500416A (ja) | デュタステリド及びプロピレングリコールモノラウレートを含有する医薬組成物及びその調製方法 | |
| JP2023027071A (ja) | 二成分組成物 | |
| PH12020552098A1 (en) | Solid preparation composition for oral application of colonic purgative containing anhydrous sodium sulfate, potassium sulfate, anhydrous magnesium sulfate, and simethicone | |
| JP2018039810A5 (enExample) | ||
| RU2017139874A (ru) | Композиция для ухода за полостью рта | |
| JP2015528515A5 (enExample) | ||
| RU2016137165A (ru) | Композиция для применения при лечении боли, связанной с межпозвоночным диском | |
| WO2019122165A1 (en) | Two component compositions | |
| JP2017508004A5 (enExample) | ||
| RU2011134414A (ru) | Комбинация фульвовой кислоты для лечения различных состояний и болезней | |
| TH91885B (th) | รูปแบบยาที่ร่วมกันชนิดใหม่ | |
| RU2016145411A (ru) | Комбинация брекспипразола и налмефена, и ее применение для лечения синдрома химической зависимости | |
| TH91885A (th) | รูปแบบยาที่ร่วมกันชนิดใหม่ | |
| JP2012072106A5 (enExample) |